From Buysellsignals today :Phosphagenics, Australia's 12th...

From Buysellsignals today :
Phosphagenics, Australia's 12th largest pharmaceuticals, biotechnology & life sciences company by market capitalisation, has strengthened above its trend. The MACD indicator (12 day EMA-26 day EMA) is positive, a bullish signal. In the past 26 days this indicator was positive for 19 days, suggesting further upside. The stock price surged 1.50c (or 9.4%) to close at 17.50c. Compared with the All Ordinaries index, which rose 110.2 points (or 2.6%) on the day, this was a relative price change of 6.8%.
ts price change has been positive in the short-term over 5 days, medium-term over 3 months and over the period of 1 year. Its short term rises have been combined with strong volume resulting in strong momentum
rises over 1 day.
Significantly its price of 17.50c is at a premium of 29% to its 200-day moving average price of 13.56c. Its 52-week range has been 18.50c to 9.70c; it is trading at a discount of 5.4 % to its 52-week high and a premium of 80.4 % to its 52-week low. $1,000 invested exactly one year ago is now worth $1,591 of which $591 is a capital gain.

Relative Valuation Indicators - RVITM - Technical Analysis

The price advanced 6.1% in the last week and soared 16.7% in the last month.
This has been propped up by high volume of 3.7 times average for the week and by firm volume 1.5 times average for the month.
Compared with the All Ordinaries index which rose 8.4% for the month, this represented a relative price increase of 8.2% for the month.
In the Australian market of 1,209 stocks and 63 units traded today, the stock has a 6-month relative strength of 94 which means it is beating 94% of the market.
A price rise combined with a high relative strength is a bullish signal.
The price to 50-day EMAP ratio is 1.2, a bullish indicator. In the past 50 days this ratio has exceeded 1.2 just twice suggesting a resistance level.The 50-day EMAP has increased to 15.05c. An increase is another bullish indicator.
The Moving Average Convergence Divergence (MACD) indicator of 12-day Exponential Moving Average (EMA) minus the 26-day EMA is positive suggesting a bullish signal. Both the 12-day EMA as well as the 26-day EMA are rising, another bullish signal.
The price to 200-day MAP ratio is 1.29, a bullish indicator. In the past 200 days this ratio has exceeded 1.29 20 times suggesting further upside. The stock is trading above both its MAPs and the 50-day MAP of 14.74c is higher than the 200-day MAP of 13.56c, another bullish indicator.